Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05886894 · ClinicalTrials.gov registry record

Air Optix Plus HydraGlyde Multifocal Daily/Extended Wear Contact Lenses

A clinical trial, sponsored by Alcon Research.

Completed
Registry status
351
Enrollment target

NCT05886894 is a clinical trial that has completed, run by Alcon Research. The registered enrollment target is 351 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05886894 has completed, sponsored by Alcon Research.

COMPLETED
Registry status
351 participants
Enrollment target

Study Summary

The purpose of this Post-Market Clinical Follow-Up (PMCF) study is to assess long term performance and safety of Air Optix plus HydraGlyde Multifocal soft contact lenses in a real-world setting when worn as daily wear or extended (overnight) wear.

Interventions

  • DEVICE Lotrafilcon B multifocal soft contact lenses
  • DEVICE Comfilcon A multifocal soft contact lenses

Trial Details

FieldValue
Enrollment Target 351 participants
Start Date 2023-08-08
Est. Completion 2025-06-20

Sponsor

Alcon Research

275 total trials

What the Registry Record Tells You About NCT05886894

The ClinicalTrials.gov registry entry for NCT05886894 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 351 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Lotrafilcon B multifocal soft contact lenses is the first listed.

NCT05886894 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05886894 about?

NCT05886894 is a clinical study titled "Air Optix Plus HydraGlyde Multifocal Daily/Extended Wear Contact Lenses". The purpose of this Post-Market Clinical Follow-Up (PMCF) study is to assess long term performance and safety of Air Optix plus HydraGlyde Multifocal soft contact lenses in a real-world setting when worn as daily wear or extended (overnight) wear.

What is the current status of trial NCT05886894?

This trial is currently completed. The enrollment target is 351 participants. The study started on 2023-08-08. Estimated completion is 2025-06-20.

What interventions are being tested in trial NCT05886894?

The interventions under investigation include: Lotrafilcon B multifocal soft contact lenses (DEVICE), Comfilcon A multifocal soft contact lenses (DEVICE).

Who is sponsoring clinical trial NCT05886894?

This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.